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Abstract 
Background: CD4 cells are a type of white blood cells that plays a significant role in protecting humans from infec-
tious diseases. Lack of information on associated factors on CD4 cell count reduction is an obstacle for improvement 
of cells in HIV positive adults. Therefore, the main objective of this study was to investigate baseline factors that could 
affect initial CD4 cell count change after highly active antiretroviral therapy had been given to adult patients in North 
West Ethiopia.
Methods: A retrospective cross-sectional study was conducted among 792 HIV positive adult patients who already 
started antiretroviral therapy for 1 month of therapy. A Chi square test of association was used to assess of predic-
tor covariates on the variable of interest. Data was secondary source and modeled using generalized linear models, 
especially Quasi-Poisson regression.
Results: The patients’ CD4 cell count changed within a month ranged from 0 to 109 cells/mm3 with a mean of 
15.9 cells/mm3 and standard deviation 18.44 cells/mm3. The first month CD4 cell count change was significantly 
affected by poor adherence to highly active antiretroviral therapy (aRR = 0.506, P value = 2e−16), fair adher-
ence (aRR = 0.592, P value = 0.0120), initial CD4 cell count (aRR = 1.0212, P value = 1.54e−15), low household 
income (aRR = 0.63, P value = 0.671e−14), middle income (aRR = 0.74, P value = 0.629e−12), patients without cell 
phone (aRR = 0.67, P value = 0.615e−16), WHO stage 2 (aRR = 0.91, P value = 0.0078), WHO stage 3 (aRR = 0.91, P 
value = 0.0058), WHO stage 4 (0876, P value = 0.0214), age (aRR = 0.987, P value = 0.000) and weight (aRR = 1.0216, 
P value = 3.98e−14).
Conclusions: Adherence to antiretroviral therapy, initial CD4 cell count, household income, WHO stages, age, weight 
and owner of cell phone played a major role for the variation of CD4 cell count in our data. Hence, we recommend 
a close follow-up of patients to adhere the prescribed medication for achievements of CD4 cell count change 
progression.
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Background
Globally, about 330,000 children were infected with HIV 
in 2011, and 90% of these infections occurred in Sub-
Saharan Africa mainly through mother to child trans-
mission [1]. About 38.1 million people were infected by 
HIV virus in the world at the end of 2014 and about 25.3 
million people died with AIDs related illness [2]. In 2014, 
about 39.9 million people were living with HIV and the 
global prevalence rate was 0.8% [3]. In 2009 alone, an 
estimated 1.3 million adults and children died because 
of HIV/AIDs in Sub-Saharan African [4]. Most of the 
people living with HIV/AIDS in Africa are between age 
15 and 49, which is the prime age of working [5]. Fur-
thermore, the International Labor Organization (ILO) 
indicated that in 2005 an estimated number of 2 million 
workers were unable to work in Africa due to HIV/AIDs 
illness; and this figure was doubled in 2015 [6]. During 
the period, around 25.8 million people were living with 
HIV virus in Sub-Saharan Africa, accounting for 67.7% 
of the global total [6]. The impact of HIV/AIDs in Africa, 
on the workforce, increases expenditure on the one hand 
and decreases productivity on the other [6]. In Ethiopia, 
about 730,000 people were living with HIV and among 
these 23,000 died due to AIDs. An estimated prevalence 
among pregnant women was 1.2%, and one of every 3 
children born to these women got infected with HIV [7]. 
In Amhara Region, all HIV prevalence was estimated to 
be 1.6% [8] and the prevalence among women attending 
prenatal clinics from 1999 to 2000 was more than 18% 
[9]. Therefore, the Amhara region is among the regions 
that require special attention to HIV- related prob-
lems such as recovery of CD4 cell count to highly active 
antiretroviral therapy (HAART) [10].
Although the current HIV/AIDs surveillance estimates 
indicate some encouraging signs that the epidemic is sta-
bilizing, the observed changes are not sufficient enough 
to be compared to the desired goals of response against 
the epidemic [11]. Availability of information about fac-
tors that affect CD4 cell count in the study area at initial 
stage of treatment is important for HIV patients to have 
long life period [12]. Information on the rate of initial 
HAART regimen change and its predictor in Ethiopia 
is scarce [13, 14]. There is a limited data regarding fac-
tors that predict initial CD4 cell count change to HAART 
medication in the study area [14]. In particular, there are 
no studies that examine how patient-related factors relate 
to each other (interact) and their subsequent influence 
on initial CD4 cell count change [15]. The purpose of this 
study is thus to identify whether or not specific clinical 
and socio-demographic factors present at the baseline 
influence first month CD4 cell count change among HIV 
positive adults in Amhara region (North west Ethio-
pia) [16]. Therefore, the present study emphasizes the 
role of covariates (predictors) that are thought to affect 
the parameters of the conditional distribution of events, 
given the covariates. The knowledge and understanding 
of such factors is important given the increasing number 
of patients enrolled in HAART [16]. This improvement 
helps to reduce dropout patients from the treatment. The 
results of this research can further be used to shape com-
munication and counseling prior to treatment initiation.
Methods
Study materials and setting
The data for this study consisted of secondary data, 
records of social, demographic and clinical character-
istics of 792 adult HIV patients recorded after 1 month 
of therapy by HIV care providers. A Chi square test of 
association was used to assess predictors of the response 
variable. The study was cross-sectional, targeted for 6036 
HIV/AIDS patients who visited Felege-Hiwot Referral 
and Teaching Hospital and Health Research center in 
Bahir Dar, Ethiopia, under the follow-up of ART from 
September 2005 to August 2012.
Inclusion criteria
Adult patients, whose ages were 15+  years, with a CD4 
cell count below 200  cells/mm3 or patients with World 
Health Organization (WHO) stage IV of HIV disease 
regardless of CD4 cell count, enrolled at Felege-Hiwot 
Referral and Teaching Hospital were included under this 
study.
Sample size and sampling technique
Out of the targeted HIV/AIDS patients, 792 were 
selected using stratified random sampling technique con-
sidering their residence area as strata using 95% level of 
confidence and 5% marginal error.
Data collection tools and procedures
The available information was first observed and dis-
cussed with health care service providers at ART section 
from the hospital. Data was extracted using data extrac-
tion format developed by the investigators in consultation 
with health service providers. All relevant information 
was collected by health care service providers after theo-
retical and practical orientations. Charts of patients were 
retrieved using the patients’ registration card number 
which was found in the electronic database system.
Data quality
The quality of the data was controlled by data control-
lers from the ART section as well as the regional health 
research center who had intensive ART training from the 
Ministry of Health for these and other purposes. Data col-
lectors got introductions about definitions of variables in 
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the questionnaires. The data extraction tools and variables 
included in the analysis were pre-tested for consistency of 
understanding, review of tools and completeness of data 
items on 45 random charts. Based on the pilot data result, 
the necessary amendments were made on the final data 
extraction format. The retrieval process was closely moni-
tored by the principal investigator throughout the data 
collection period. Both predictor and response variables 
were checked regularly for completeness of information. 
Any problem traced was immediately communicated to 
data collectors for giving corrections.
Variable of interest
The variable of interest for this study was CD4 cell count 
change per mm3. The response variable was count data.
Independent variable
The potential predictor variables for this study were age in 
years, weight in kg, baseline CD4 cell count, gender (male, 
female), educational status (no education, primary, second-
ary and tertiary), disease disclosure (disclosed their disease 
to family members, closed the disease to family members), 
residential area (rural, urban), WHO stages (stage 1, stage 
2, stage 3 and stage 4), adherence to HAART (poor, fair and 
good), level of income (low, middle and high), marital sta-
tus (living with partner, living without partner), and owner 
of cell phone (with cell phone, without cell phone).
The standard model for count data is Poisson distribu-
tion. It is, therefore, useful at the outset to review some 
fundamental properties and characterize results of the 
Poisson distribution. If the discrete random variable Y 
has Poisson distribution with intensity or rate parameter 
μ, μ > 0 and t is the exposure defined as the length of time 









= µt. If the time period equals to 
unity, then its density given in (1) equals
Equality of mean and variance of Poisson distribution 
is referred to as the equi-dispersion property of Poisson 
which is mostly violated in real life data [18].
In generalized linear models, the method of maxi-
mum likelihood estimation is usually used to estimate the 
parameters in the given model [19]. To define likelihood, 
we have to specify the form of distribution of observation; 
while to define quasi-likelihood function, we need to spec-
ify only the mean–variance relationship and then apply 
quasi-likelihood for parameter estimation [20]. The impor-
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point of view depends on mean–variance relation [20]. 
In over-dispersed Poisson model, an extra parameter is 
included which estimates how much larger the variance is 
than the mean [21]. This parameter estimate is then, used 
to correct the effects of the larger variance on the P val-
ues [22]. In the over-dispersed distribution, one alternative 
approach to fit extra dispersion parameter which accounts 
for that extra variance is a Quasi-Poisson model. It has two 
parameters, namely mean, μ and over-dispersion param-
eter θ such that variance is a linear function of mean [23]. 
Hence for random variable y that follows Quasi-Poisson 
distribution, we have
for ∅ > 1, we have over-dispersion relative to Poisson. 
Applying iteratively re-weighted least squares in the more 
general case involves working with weights say W ∗ = µ
∅
 . 
This implies that when variance is proportional to mean 
(not necessarily equal to mean), Poisson estimator is maxi-
mum Quasi-Poisson likelihood estimator and the model 
is said to Quasi-Poisson regression model [21]. The quasi-
likelihood function K(yi, µi) for each independent obser-
vation, yi is defined as
where V is some known function and suppose the expecta-
tion, µi is some function of parameters βi. Another alter-
native for modeling over-dispersion is a negative binomial 
regression model [24] with two parameters and having a 
form of the Poisson distribution in which the distribution’s 
parameter itself is considered as random variable. The first 
two moments of negative binomial regression model are 
[24].
If θ  =  0, there will be no unobserved heterogeneity 
which results in Poisson variance (Poison model is a spe-
cial case of negative binomial when θ = 0); and if θ > 0, 
variance will be greater than mean and becomes over-
dispersed [17]. Using weighted least squares; these mod-
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provided all other elements are zero. The mean-weight 
relation that exists in model Eq. (6) provides us with full 
comparison between Quasi-Poisson and negative bino-
mial models where Quasi-Poisson weights are directly 
proportional to the mean and have concave relation to 
the mean of negative binomial [20].
Therefore, the two models, Quasi-Poisson and nega-
tive binomial regression models; are to be considered 
as potential candidates for fitting over-dispersed data. 
Different scholars such as Ver Hoef [20], Gardner [23], 
Power [25] and Potts [26] gave different decisions and 
comments at different times about the models appro-
priate to over-dispersed data. Therefore, we compared 
the two models using the following two approaches; 
comparing the values of log-likelihood, AIC and BIC 
to assess goodness-of-fit based on our data for the two 
models as shown in Table 2 [27]; and using mean–vari-
ance and mean-weight relation and finding the cut-off- 
point (boundary value) where the two curves cross each 
other as shown in Eqs.  (3), (5), (6) and (refer Fig. 1). To 
do this, one can equate the two mean–variance relation 
equations of the two models (3) and (5) after predicting 
over-dispersed parameters for the two models separately. 
Then, one can find the mean value that makes the two 
graphs cross each other. We consider this value as cut-off 
point or boundary value. If the mean of response vari-
able (CD4 cell count for our case) is less than the cut-off 
point, we have to consider negative binomial; while if the 
mean of the variable of interest is greater than the cut-off 
point, we need to consider a Quasi-Poisson model [20] 
(refer to Fig. 1).
Data analysis
The variables under study were summarized using 
descriptive statistics such as median for continuous 
variable and proportions for categorical variables. The 
data was also analyzed using generalized linear models 
using Quasi-Poisson regression model. The mean–vari-
ance relation, information criteria and the value of Chi 
square divided by its degree of freedom were used to 
select the model that fits the data appropriately. Change 
of deviance was used to measure the extent to which 
the fit of the model was improved when extra variables 
were added to the model. The main effects and com-
bination of two ways interaction were fitted, provided 
that attention was given to hierarchical principle of 
model fitting. The mean–variance relations for nega-
tive binomial and Quasi-Poisson were solved simulta-
neously to get the value (cut-off points) where the two 
curves meet each other. The mean of response variable 
and cut-off points were compared to each other for the 
two models to select the one which had smaller varia-
tion for response variable. The model selected for anal-
ysis was the one with smallest information criteria and 
smallest dispersion parameter and its goodness-of-fit 
was assessed using Hosmer–Lemeshow goodness-of-
fit statistic [28]. Influential observations were identified 
using cook’s distance against observations [29]. Finally, 
the linear predictor and its square on the response vari-
able were important for checking appropriateness of 
link function for the selected model [28]. Data analy-
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Fig. 1 Mean-weight relationship for Quasi-Poisson and negative binomial models
Page 5 of 10Seyoum et al. AIDS Res Ther  (2016) 13:36 
Results
In Table 1, out of the sample of 792 patients, 40.9% were 
from rural areas while 59.1% were residing in urban 
areas; 50.6% were female and 49.4% were male and 44.8% 
were living with their partners and 55.2% were living 
without partners. About 47.3% of them disclosed their 
disease to family members and the rest did not. Of these 
patients, 46.1% owned cell phone. Lastly 25.5, 44.3 and 
30.2% of the patients had good, fair and poor adherence, 
respectively.
After 1 month of treatment, the change in CD4 cell count 
ranged from 0 to 109 cells/mm3 with mean 15.9, standard 
deviation 18. 44 and median 7 cell/mm3 (see Fig. 2). Figure 2 
also shows that 17.55% of the patients had 4 CD4 cells/mm3 
and only 0.63% had 109 CD4 cells/mm3, and the distribu-
tion indicated that variance is about 21 times the mean and 
this is an indicator of over-dispersed distribution. Using 
Pearson’s Chi square statistic, deviance divided by degree 
of freedom, the over-dispersion parameter for Quasi Pois-
son was ∅ˆ = 1.49, which showed that the variance is 49% 
larger than mean [20]. Using these estimated values, Eqs. (3) 
and (5) for our data, mean value (cut-off point) which made 
over-dispersion for Quasi-Poisson [17] and negative-bino-
mial [24] equal to each other was μ = 10.5 cells/mm3 which 
is less than the mean of CD4 cell count change (15.9 cells/
mm3) for our analysis. Therefore, based on the selection cri-
terion, the Quasi-Poisson was selected to fit our data [20]. 
The two models were also compared using information 
criteria such as Akakai and Bayesian information criterion 
[30], and the result is given in Table 2.  
From Table 2, we observed that deviance was less than 
Pearson Chi square for both models, but AIC and BIC 
were smaller for Quasi-Poisson which indicated that 
Quasi-Poisson was preferable. Hence parameter estima-
tion and identification of predictors of initial CD4 cell 
count should be conducted using the selected model 
(Quasi-Poisson model).
From Table  3, considering adherence as a predic-
tor variable, compared to good adherence, log of the 
expected CD4 cell count change difference between poor 
adherent patients and good adherent patients was about 
−0.68 cells/mm3, and the difference between fair adher-
ent and good adherent patients was −0.525  cells/mm3 
per month. In other words, the CD4 cell count change 
for poor adherents was 0.51 times that of good adherent 
patients (aRR =  0.51, P value =  2e−16). And the rate of 
change of CD4 cell count for fair adherent patients was 
0.59 times (aRR =  0.59, P value =  0.0120) that of good 
adherent patients keeping the other variables constant. 
For one year increase of the age of a patient, the log of 
expected CD4 cell count change decreased by 0.012 cells/
mm3 (aRR = 0.986, P value = 2.38e−12).
The other predictor variable with significant effect for the 
variable of interest was found to be initial CD4 cell count 
(refer to Table 3). For 1 cell/mm3 increase of initial CD4 cell 
count, the log of expected change of CD4 cell count was 
increased by 0.003 (aRR = 1.02, P value = 1.54e−15), keep-
ing the other variables constant. A patient with low house-
hold income experienced lower CD4 cell count change as 
compared to the household with high income (aRR = 0.63, 
P value = 6.71e−14). However, a patient with middle house-
hold income, CD4 cell count change was lower than that 
with high household income. The variable ownership of cell 
Table 1 Baseline socio-demographic and  clinical charac-
teristics of the HAART patients (n = 792)
Characteristics Median n (%)
Base line weight in kg 62 (58–70)
Baseline CD cell count 134 (113–180)
Age in years 36 (28–48)
First month CD4 cell count change 7 (5–24)
Gender
 Male 391 (49.4)
 Female 401 (50.6)
Educational background
 No educ 160 (20.2)
 Primary 205 (25.9)
 Secondary 273 (34.5)
 Tertiary 154 (19.4)
Residence area
 Urban 468 (59.1)
 Rural 324 (40.1)
Marital status
 Living with partner 355 (44.8)
 Living without partner 437 (55.2)
Contribution to household income
 Low income 355 (44.8)
 Middle income 346 (43.7)
 High income 91 (11.5)
WHO stage of HIV stage
 Stage I 101 (12.8)
 Stage II 258 (32.6)
 Stage III 199 (25.1)
 Stage IV 234 (29.5)
Whether or not the patient disclosed the disease
 Disclosed to family members 375 (47.3)
 Closed the disease to family members 417 (52.7)
Owner of cell phone
 Yes 365 (46.1)
 No 427 (53.9)
First month HAART adherence
 Poor 239 (30.2)
 Fair 351 (44.3)
 Good 202 (25.5)
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Fig. 2 Monthly distribution of changes in CD4 cell count after 1 month of treatment
Table 2 Comparison of Quasi-Poisson and negative binomial using information criteria
Criteria Quasi-Poisson Negative-binomial
Value d.f Vale/d.f. Value d.f Vale/d.f.
Deviance 1090.457 73 1.411 869.625 73 1.128
Pearson Chi-square 1152.646 73 1.491 926.054 73 1.198
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Fig. 3 Interaction plot between owner of cell phone and age of patients
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phone had significantly affected CD4 cell count change for 
1 month of therapy. Hence, the expected change of CD4 
cell count for a patient without cell phone decreased by 
43% (aRR = 0.67, P value = 0.0226) as compared to oth-
erwise identical patients with a cell phone. With regard to 
WHO stages, stages 2 and stage 3 patients’ CD4 changes 
were lower than that of stage 1 patients. Table 3 also shows 
significant interaction effects with main effects and the fol-
lowing were significant interaction effects in Table 3.
Interaction effects of owner of cell phone and age 
of patients
Naturally, as age of a patient increases, CD4 cell count 
decreases, but the decreasing rate of those patients with 
cell phone was less likely than that of patients without cell 
phone (aRR = 0.987, P value = 0.007) (refer to Table 3). 
Figure  3 indicates that the decreasing rate of patients 
with owner of cell phone is less likely as comapred to 
those patients without cell phone.
Table 3 Parameter estimates using Quasi-Poisson model
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘’ 1
Coefficients Coefficients Exp (coefficients) Std. error t value Pr (>|t|)
(Intercept) 1.3620765 3.9012 0.21603 6.305 4.84e−10***
Age −0.0121754 0.988 0.00171 −7.126 2.38e−12***
Weight 0.0213740 1.0216 0.00277 7.706 3.98e−14***
Initial.CD4 0.0034295 1.0212 0.00042 8.143 1.54e−15***
Gender (ref = female)
 Gender male −0.0144168 0.9856 0.02292 −0.629 0.5296
Residence (rural)
 Urban 0.0412981 1.0422 0.02309 1.789 0.0740
Education (ref. = no edu.)
 Educ. primary 0.0191098 1.0192 0.04796 0.398 0.6904
 Educ. secondary 0.0280730 1.02847 0.04215 0.666 0.5056
 Educ. tertiary 0.0627961 1.0648 0.04688 1.340 0.1808
Marital status (ref = without part)
 With part 0.0939004 1.09845 0.03196 2.938 0.0034**
Household income (ref = high)
 Low income −0.4627385 0.62955 0.06061 −7.634 6.71e−14***
 Middle income −0.3010270 0.74322 0.04312 −6.982 6.29e−12***
Owner of cell phone (ref = with cell phone)
 Without phone −0.4021422 0.66888 0.04867 −8.263 6.15e−16***
Adherence (ref = good)
 Adherence fair −0.5250367 0.5921 0.0596023 −2.517 0.0120*
 Adherence poor −0.6800367 0.50621 0.0596023 −1.267 <2e−16***
Level of exposedness (ref = exposed)
 Not exposed −0.0968024 0.9077 0.0423628 −2.285 0.0226*
WHO stages (ref = stage 1)
 WHO. Stage stage 2 −0.1039865 0.90521 0.0389829 −2.667 0.0078**
 WHO. Stage stage 3 −0.0949728 0.90981 0.0500913 −1.896 0.0058*
 WHO. Stage stage 4 −0.1321290 0.87623 0.0572926 −2.306 0.0214*
Marital status* adherence (ref = good adherence and living with partner)
 Living with partner* poor adherence −2.316 0.09912 0.7866 −0.261 0.461*
 Living without partner* fair adherence −2.415 0.08923 0.7827 −0.234 0.002*
Owner of cell phone* age (ref = with cell phone)
 With cell phone* age −0.013 0.98721 0.0050 −2.598 0.007*
Marital status* initial CD4 cell count (ref = without partner)
 Living with partner* CD4 0.007 1.007 0.0010 2.651 0.000*
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Interaction between adherence and marital status
The log of CD4 cell count change for patients with poor 
and fair adherence living without partners decreased by 
2.316 and 2.415, respectively as compared to patients with 
good adherence living with their partners (aRR =  0.099, 
P value =  0.003 for poor adherence) and (aRR =  0.089, 
P value = 0.002 for fair adherent patients) (see Table 3). 
Figure  4 shows that the incident rate of CD4 cell count 
change for patients living with partners was by far better 
than those patients living without their partners.
Interaction effects of marital status and initial CD4 cell 
count
Another significant interaction effect on CD4 cell count 
change based on 1 month therapy was marital status with 
initial CD4 cell count. In this 1 month therapy, CD4 cell 
count change appreciated as initial CD4 count increased, 
but it was more accelerated for patients living with part-
ners (refer to Fig. 5).
Discussions
In a month of therapy, CD4 cell count change was highly 
affected by age, weight, initial CD4 cell count, marital 
status, income, cell phone ownership, adherence, level of 
exposedness and WHO stages from the main effect and 
age with owner of cell phone, marital status with adher-
ence and marital status with initial CD4 cell count from 
the interaction effect. In this study, as age of an individual 
increased, CD4 cell count decreased. This is also supported 
by previous joint longitudinal study [16]. In adherence cat-
egory, poor adherent patients who did not properly take 
their medication on time, lose their CD4 cell count. On 
the other hand, patients with good adherent, who took 
pills on time regularly, increased their CD4 cell count. A 
patient living with his/her partner may be encouraged 
or reminded to take his/her medication on time and this 
contributes to increase CD4 cell count. A patient who 
does not expose the disease to family members may not 
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Fig. 5 Interaction effect between initial CD4 and marital status of patients
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only when nobody is around; and this leads to reduction 
of CD4 cell count. Naturally, aged people are less likely to 
have high CD4 cell count as compared to young people. 
But the decreasing rate of CD4 cell count as age increases 
was different for patients having cell phone and without 
having cell phone. Hence patients with cell phone had less 
decreasing rate as compared to those patients without cell 
phone.
The significant result of initial CD4 cell count on cur-
rent CD4 cell count obtained under this study is con-
sistent with a previous study [27]. Hence, a patient who 
started HAART with high initial CD4 cell count had high 
CD4 cell count change. On the other hand, an insignifi-
cant result of gender on CD4 cell count change in this 
study contradicted with previous research [27] and is 
supported by another research [14]. A significant result 
for marital status obtained in this study is supported 
by another previous study [11]. The significant result of 
WHO stages on CD4 cell count in this study is also sup-
ported by previous longitudinal study [11].
Limitations
One limitation of this study was that the interactions 
between variables were identified in model fit techniques 
which were not pre-specified or expected during data 
collection. Therefore, detail information on why these 
interactions affect on first month CD4 cell count change 
was not collected and therefore, the reason for some of 
these findings cannot be explained. Furthermore, this 
study focused on first month CD4 cell count change. 
There was no evidence whether or not the factors that 
affected the CD4 cell count change in first month therapy 
can also affect the change of CD4 cell count of longitudi-
nal data for the same cohort. The study also tried to iden-
tify special characteristics of HIV positive adults and we 
should not generalize the result to the whole HIV positive 
people, since the investigation did not include HIV posi-
tive patients whose age were less than 15  years. Hence, 
the result may not be the same on this issue if we incor-
porate all HIV positive people whose ages are less than 
15 years; and this needs further investigation. Therefore, 
for researchers who want to study this gap it can be con-
sidered as potential for further study.
Conclusions
Quasi-Poisson regression model was a better fit for the 
given data, and variables that significantly predict the 
response variable were identified using this model. The 
result under this investigation indicated that CD4 cell 
count change of HIV positive people had been affected 
by several factors. There should be a special attention 
and intervention for HIV positive adults, especially for 
those who had low CD4 cell count change, for pre-treat-
ment counseling and awareness creation. The study also 
tried to identify a certain group of patients who were 
with maximum risk of CD4 cell count change and need 
high intervention for counseling and awareness crea-
tion. Hence, we recommend that the Ministry of Health 
(MOH) give due attention for awareness creation so that 
patients should expose the disease to family members 
and adhere to HAART directed by health care service 
providers on time using the alarm of their cell phone as 
remembrance.
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